Target Details
| UniProt AC | O95136 |
|---|---|
| Gene Symbol | S1PR2 |
| Protein Name | Sphingosine 1-phosphate receptor 2 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00001 (7tm_1) |
Summary
- Multi-target molecules 90
- Clinical molecules 0
- Avg pChEMBL 7.51
KEGG Pathways (2)
Associated Diseases (1)
Active Molecules (90)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
GSDSPSURUKLGBL
|
7.3 | IC50 | 2 | — | |
UOMCGLVLCMYTTQ
|
7.3 | IC50 | 2 | — | |
RFNNVHCCTIWJLY
|
7.2 | IC50 | 4 | — | |
GYRSLHWASFQOPP
|
7.2 | IC50 | 4 | — | |
CMYBPDPQGCRMDY
|
7.2 | IC50 | 2 | — | |
RNDCUJZLFBWJHF
|
7.2 | IC50 | 3 | — | |
PGLFYYYVMFEVNN
|
7.1 | IC50 | 4 | — | |
LPFGMPGBYMGNTK
|
7.1 | IC50 | 4 | — | |
GRBYKZJOZJYFPB
|
7.1 | IC50 | 3 | — | |
XZWUWZDFEBVUJQ
|
7.1 | IC50 | 4 | — | |
AFPYVDIMHNINIS
|
7.0 | IC50 | 4 | — | |
YHDAWQLKEJHZMN
|
7.0 | IC50 | 4 | — | |
AAEVPRISMKXZKU
|
7.0 | IC50 | 4 | — | |
WMLSDMINRWPYKX
|
7.0 | IC50 | 3 | — | |
AMJOZICHTKJDOI
|
7.0 | IC50 | 3 | — | |
KARRQFDDSYYFAE
|
7.0 | IC50 | 4 | — | |
BGPIKLDZOZBUEW
|
6.9 | IC50 | 4 | — | |
ZQAPROQSGXAHSW
|
6.9 | IC50 | 4 | — | |
WUCGGZATYNFGIA
|
6.8 | IC50 | 4 | — | |
YTTNOAFOCBYIIG
|
6.8 | IC50 | 4 | — | |
LVLCOLBUGCDLPB
|
6.8 | IC50 | 4 | — | |
GJSCDTCSBXBNCQ
|
6.7 | IC50 | 3 | — | |
NEAYDTITWAMODK
|
6.7 | IC50 | 2 | — | |
XDSPSYJWGHPIAZ
|
6.6 | IC50 | 4 | — | |
CDEPDWBJGIUHRS
|
6.6 | IC50 | 5 | — | |
ODKLTWJRUVYDRU
|
6.5 | IC50 | 5 | — | |
IHLGWTMHFNRKTD
|
6.3 | IC50 | 3 | — | |
ROTPOJPBVJTWLI
|
6.2 | IC50 | 5 | — | |
LSZRFUXALRHLHB
|
6.2 | IC50 | 3 | — | |
FYASEYBMRPOWCR
|
6.2 | IC50 | 2 | — | |
IHJCKBWPCNFLBM
|
6.2 | IC50 | 5 | — | |
IHJCKBWPCNFLBM
|
6.2 | IC50 | 5 | — | |
POPQMXAKAVJFNJ
|
6.2 | IC50 | 4 | — | |
IILANYBHYYNGJK
|
6.1 | IC50 | 5 | — | |
WGQPJPGVHXXIAT
|
6.1 | IC50 | 3 | — | |
UCEGDYDPOSBUTP
|
6.1 | IC50 | 6 | — | |
XPZPTGRFTGBSAI
|
6.1 | IC50 | 4 | — | |
UKBGNIASULYWLD
|
6.1 | IC50 | 2 | — | |
DUKRXYQQFMFORW
|
6.0 | IC50 | 3 | — | |
UUODWPRHRNIITI
|
6.0 | IC50 | 2 | — |